tirzepatide surmount-1 trial weight loss non-diabetic Read now: The SURPASS-EARLY found that starting #tirzepatide early in #type2diabetes led to greater improvements in blood sugar, body weight, and waist size than intensified standard care. https://bit.ly/3RWnB8m REDEFINE 4 vs SURMOUNT: how

Injectables, inevitably, are honing their marketing too: Galderma, maker of Sculptra and Restylane, introduced its SCULPT & LIFT protocol, updating injectable guidance after a study on medication-driven weight loss

Common Myths About GLP-1 Medications and Nutrition Theres a lot of misinformation about GLP-1 medications online, which can create unnecessary worry

Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis

By comparison, the risk of death among sleep apnea patients was 1% for those on a GLP-1 versus 2.5% for those who weren't